135 related articles for article (PubMed ID: 34342803)
1. The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4.
Piskacek M; Otasevic T; Repko M; Knight A
Stem Cell Rev Rep; 2021 Oct; 17(5):1934-1936. PubMed ID: 34342803
[No Abstract] [Full Text] [Related]
2. Application of the Yamanaka Transcription Factors
Aguirre M; Escobar M; Forero Amézquita S; Cubillos D; Rincón C; Vanegas P; Tarazona MP; Atuesta Escobar S; Blanco JC; Celis LG
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761837
[TBL] [Abstract][Full Text] [Related]
3. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
4. Selective killing of leukemia cells: Yamanaka factors' new trick.
Xie H; Graf T
Stem Cells; 2020 Jul; 38(7):818-821. PubMed ID: 32159910
[TBL] [Abstract][Full Text] [Related]
5. Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells.
Wang J; Huang V; Ye L; Bárcena A; Lin G; Lue TF; Li LC
Stem Cells Dev; 2015 Feb; 24(3):345-53. PubMed ID: 25232932
[TBL] [Abstract][Full Text] [Related]
6. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the transcription factors Oct4, Sox2, Klf4, c-Myc or Nanog has different effect on teratoma growth.
Villodre ES; Felipe KB; Oyama MZ; Oliveira FH; Lopez PLDC; Solari C; Sevlever G; Guberman A; Lenz G
Biochem Biophys Res Commun; 2019 Sep; 517(2):324-329. PubMed ID: 31353083
[TBL] [Abstract][Full Text] [Related]
8. Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4.
Malak PN; Dannenmann B; Hirth A; Rothfuss OC; Schulze-Osthoff K
Cell Cycle; 2015; 14(23):3748-54. PubMed ID: 26654770
[TBL] [Abstract][Full Text] [Related]
9. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
10. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
[TBL] [Abstract][Full Text] [Related]
11. Folate Receptor Alpha Upregulates Oct4, Sox2 and Klf4 and Downregulates miR-138 and miR-let-7 in Cranial Neural Crest Cells.
Mohanty V; Shah A; Allender E; Siddiqui MR; Monick S; Ichi S; Mania-Farnell B; G McLone D; Tomita T; Mayanil CS
Stem Cells; 2016 Nov; 34(11):2721-2732. PubMed ID: 27300003
[TBL] [Abstract][Full Text] [Related]
12. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
[TBL] [Abstract][Full Text] [Related]
13. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors.
Garcia-Lavandeira M; Saez C; Diaz-Rodriguez E; Perez-Romero S; Senra A; Dieguez C; Japon MA; Alvarez CV
J Clin Endocrinol Metab; 2012 Jan; 97(1):E80-7. PubMed ID: 22031517
[TBL] [Abstract][Full Text] [Related]
14. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
Liu X; Huang J; Chen T; Wang Y; Xin S; Li J; Pei G; Kang J
Cell Res; 2008 Dec; 18(12):1177-89. PubMed ID: 19030024
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
[TBL] [Abstract][Full Text] [Related]
16. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
17. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
[TBL] [Abstract][Full Text] [Related]
19. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
20. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
Qi H; Pei D
Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
